- Home
- ZTEK vs DERM Comparison
ZTEK vs DERM Comparison
Compare ZTEK & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- DERM
- Stock Information
- Founded
- ZTEK 2008
- DERM 2014
- Country
- ZTEK Canada
- DERM United States
- Employees
- ZTEK N/A
- DERM N/A
- Industry
- ZTEK Major Chemicals
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- ZTEK Industrials
- DERM Health Care
- Exchange
- ZTEK Nasdaq
- DERM Nasdaq
- Market Cap
- ZTEK 165.9M
- DERM 181.0M
- IPO Year
- ZTEK N/A
- DERM 2021
- Fundamental
- Price
- ZTEK $1.33
- DERM $6.28
- Analyst Decision
- ZTEK
- DERM Strong Buy
- Analyst Count
- ZTEK 0
- DERM 2
- Target Price
- ZTEK N/A
- DERM $10.00
- AVG Volume (30 Days)
- ZTEK 29.1K
- DERM 97.5K
- Earning Date
- ZTEK 08-13-2025
- DERM 08-11-2025
- Dividend Yield
- ZTEK N/A
- DERM N/A
- EPS Growth
- ZTEK N/A
- DERM N/A
- EPS
- ZTEK N/A
- DERM N/A
- Revenue
- ZTEK $44,936.00
- DERM $56,243,000.00
- Revenue This Year
- ZTEK N/A
- DERM $28.99
- Revenue Next Year
- ZTEK N/A
- DERM $52.61
- P/E Ratio
- ZTEK N/A
- DERM N/A
- Revenue Growth
- ZTEK 92.38
- DERM N/A
- 52 Week Low
- ZTEK $0.50
- DERM $3.54
- 52 Week High
- ZTEK $1.84
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- ZTEK 36.79
- DERM 38.72
- Support Level
- ZTEK $1.39
- DERM $6.29
- Resistance Level
- ZTEK $1.55
- DERM $7.13
- Average True Range (ATR)
- ZTEK 0.09
- DERM 0.41
- MACD
- ZTEK -0.02
- DERM -0.15
- Stochastic Oscillator
- ZTEK 2.04
- DERM 3.31
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.